Previous 10 | Next 10 |
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the third quarter of 2022 after the close of t...
Summary Outset Medical continued to face a multivariate equation of headwinds last quarter. The stock has continued its long-term downtrend whilst technical indicators aren't signalling a reversal any time soon. Fundamentally the case has changed following the company's ship h...
MedTech company Outset Medical ( NASDAQ: OM ) announced on Monday that it won a national contract from the Department of Veterans Affairs to supply its Tablo Hemodialysis System for 106 VA hospitals in the U.S. The company received the contract from the department’s...
Outset Medical, Inc. (OM) Q2 2022 Earnings Conference Call August 01, 2022 05:00 PM ET Company Participants Jim Mazzola - Vice President Investor Relations Leslie Trigg - Chair & Chief Executive Officer Nabeel Ahmed - Chief Financial Officers Conference...
Medical device companies can't market or ship their products unless the U.S. Food and Drug Administration (FDA) says they can. So when Outset Medical (NASDAQ: OM) suspended shipments of its Tablo hemodialysis system for home use in June pending FDA clearance, it was a big blow. ...
Investor Webcast and Conference Call Scheduled for 5:00 p.m. EST Outset Medical, Inc. (Nasdaq: OM) (“Outset” or the “Company”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysi...
New York, New York--(Newsfile Corp. - July 15, 2022) - Levi & Korsinsky, LLP notifies investors in Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ: OM) of a class action securities lawsuit. The lawsuit on behalf of Outset Medical investors has been commenced in the the ...
Outset Medical's thin margins present difficulties in driving cash to the bottom line. Earnings quality is therefore weak in this name and the sales to FCF mix continues to widen, a point investors probably won't pay for in FY22. We've priced the stock at $13.20 apiece leaving lit...
Uncertainty ahead of the Federal Reserve's next interest rate announcement led to a choppy session on Tuesday. Following two days of massive declines, the major U.S. equity indices ended the day mixed, as investors waited to see what the central bank would do. While the overall market showed ...
Outset Medical (NASDAQ:OM) stock plunged as much as 31.5% to touch a life-low of $13.25 on Tuesday, a day after the dialysis company halted shipments of its Tablo Hemodialysis System for use at home, prompting it to suspend its prior guidance for 2022. The company after hours o...
News, Short Squeeze, Breakout and More Instantly...
Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, today announced that it will release financial results for the second quarter of 2024 after the close of trading on...
MONTREAL, July 24, 2024 (GLOBE NEWSWIRE) -- Osisko Metals Incorporated (the “ Company ” or “ Osisko Metals ”) ( TSX-V:OM ; OTCQX:OMZNF ; FRANKFURT:0B51 ) is pleased to provide an update on the activities being carried out this summer as part of the ...